...
首页> 外文期刊>Pharmacognosy Research >Protective effect of aqueous extract of seed of Psoralea corylifolia (Somraji) and seed of Trigonella foenum-graecum L. (Methi) in streptozotocin-induced diabetic rat: A comparative evaluation
【24h】

Protective effect of aqueous extract of seed of Psoralea corylifolia (Somraji) and seed of Trigonella foenum-graecum L. (Methi) in streptozotocin-induced diabetic rat: A comparative evaluation

机译:链孢菌素诱导的糖尿病大鼠水杨提取物和风铃草种子水提物对大鼠的保护作用

获取原文

摘要

Background:Psoralea corylifolia (Somraji) and Trigonella foenum-graecum L. (Methi), important medicinal plants widely used in India as folk medicine. Local people of West Bengal traditionally used the seeds of these plants to cure diabetes.Objective:Present study was designed to investigate the antidiabetic efficacy of aqueous extract of seeds of these plants in separate or in composite manner in streptozotocin (STZ)-induced diabetic rat.Materials and Methods:Diabetes was induced by intramuscular injection of STZ at the dose of 40 mg/ml of citrate buffer/kg body weight. Fasting blood glucose (FBG), glyclated hemoglobin (HbA1C) and activities of hexokinase, glucose-6-phosphate dehydrogenase and glucose-6-phosphatase of liver in experimental animals were assessed. Hyperlipidemic state developed in the experimental diabetic rat was assessed by measuring the levels of total cholesterol, triglyceride, and lipoproteins in serum.Results:There was significant increased in the levels of FBG, HbA1C and lipid profiles along with diminution (P < 0.001) in the activities of hepatic hexokinase, glucose-6-phosphate dehydrogenase and elevation in glucose-6-phosphatase in diabetic control animals in respect to the untreated control. Significant recovery (P < 0.05) in the activities of above mentioned enzymes along with the correction in the levels of FBG, HbA1C and serum lipid profiles were noted towards the control level after the treatment of composite extract (i.e. 100 mg of Somraji: 100 mg of Methi, total 200 mg/kg body weight) than the individual extract (i.e. 200 mg of Somraji or 200 mg of Methi, per kg body weight) treatment.Conclusion:Results suggest that composite extract of above plant parts has more potent antidiabetic efficacy than the individual extract.
机译:背景:补骨脂(Somraji)和胡芦巴(Methi),是在印度广泛用作民间药物的重要药用植物。西孟加拉邦当地人传统上使用这些植物的种子来治疗糖尿病。目的:目前的研究旨在研究这些植物的种子水提取物以单独或复合方式对链脲佐菌素(STZ)诱导的糖尿病大鼠的抗糖尿病作用。材料与方法:以40 mg / ml柠檬酸盐缓冲液/ kg体重肌内注射STZ诱导糖尿病。评估实验动物的空腹血糖(FBG),糖化血红蛋白(HbA1C)以及肝中己糖激酶,葡萄糖6磷酸脱氢酶和葡萄糖6磷酸酶的活性。通过测量血清中总胆固醇,甘油三酸酯和脂蛋白的水平来评估实验性糖尿病大鼠的高脂血症状态。相对于未治疗的对照,糖尿病对照动物中的肝己糖激酶,葡萄糖6-磷酸脱氢酶的活性和葡萄糖-6-磷酸酶的升高。复合提取物处理后(即100 mg Somraji:100 mg),上述酶的活性显着恢复(P <0.05),以及FBG,HbA1C和血清脂质谱的校正均朝着对照水平。比单独的提取物(即每公斤体重200毫克的Somraji或200毫克的Methi)多出100%的甲硫磷。结论:结果表明上述植物部位的复合提取物具有更强的抗糖尿病功效比个别提取物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号